Carefully consider the Funds’ investment objectives, risk factors, charges, and expenses before investing. This and additional information can be found in Amplify Funds statutory and summary prospectus, which may be obtained by calling 855-267-3837 or by visiting AmplifyETFs.com. Read the prospectus carefully before investing.
Investing involves risk, including the possible loss of principal. Shares of any ETF are bought and sold at market price (not NAV), may trade at a discount or premium to NAV and are not individually redeemed from the Fund. Brokerage commissions will reduce returns.
Amplify ETFs are distributed by Foreside Fund Services, LLC. Proxy Voting
Weight Loss, Investors Gain: The Investment Opportunity Presented by Weight Loss Treatment Innovations
Amplify ETFs Launches The Amplify Weight Loss Drug & Treatment ETF (THNR)
Amplify ETFs Declares May Income Distributions for its ETFs
The Cannabis Recap - June 03, 2024
Amplify ETFs Earns Four Nominations for With Intelligence Mutual Fund and ETF Awards
THNR Webcast Highlights: The Rising Appeal of Weight Loss Drugs and Their Impacts Beyond the Scale
The Cannabis Recap - June 11, 2024
DIVO Commentary May 2024
The Cannabis Recap - June 24, 2024
BLOK-Chain Monthly June 2024